XML 44 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]      
Net sales $ 1,013,540 $ 936,240 $ 906,555
Cost of products sold 638,702 594,141 590,825
Gross profit 374,838 342,099 315,730
Selling expenses 105,341 102,528 99,187
General and administrative expenses 106,760 94,794 102,128
Research and development expenses 26,193 20,935 15,351
Amortization of intangibles 29,396 26,001 25,283
Income from operations 107,148 97,841 73,781
Interest and debt expense 37,957 27,942 20,126
Cost of debt refinancing 0 0 14,803
Investment (income) loss, net (1,759) (315) (46)
Foreign currency exchange loss (gain), net 1,826 (2,189) 1,574
Other (income) expense, net 7,597 (2,072) (1,122)
Income before income tax expense 61,527 74,475 38,446
Income tax expense 14,902 26,046 8,786
Net income $ 46,625 $ 48,429 $ 29,660
Average basic shares outstanding (in shares) 28,728 28,600 28,040
Average diluted shares outstanding (in shares) 29,026 28,818 28,401
Basic income per share (in dollars per share) $ 1.62 $ 1.69 $ 1.06
Diluted income per share (in dollars per share) 1.61 1.68 1.04
Dividends declared per common share (in dollars per share) $ 0.28 $ 0.28 $ 0.25